Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi
Clinical trial NCT04585893 · COMPLETED
Trial details
- NCT number
- NCT04585893
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-22
- Primary completion
- 2024-08-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.